Search Results - "Moehring, Barbara"

Second-line Afatinib or Chemotherapy Following Immunochemotherapy for the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: Real-world Effectiveness and Safety From a Multisite Retrospective Chart Review in the USA by Kim, Edward S., Kish, Jonathan K., Cseh, Agnieszka, Moehring, Barbara, Tang, Wenbo, Terlizzi, Elizabeth, Subramanian, Janakiraman

“…•Real-world study of afatinib after immunochemotherapy in patients with SqCC of the lung.•Afatinib demonstrated effectiveness and tolerability in this…”
Get full text

PB2516: ACTIGRAPHY IMPROVEMENT WITH VOXELOTOR (ACTIVE) STUDY: IMPACT OF VOXELOTOR ON PHYSICAL ACTIVITY, FATIGUE, AND SLEEP QUALITY by Shah, Nirmish, Brown, Clark, Andemariam, Biree, Idowu, Modupe, Glaros, Alexander, Cronin, Robert M., Moehring, Barbara, Hoppe, Carolyn, Dixon, Sandy, Hayward, Brooke, Purdie, David M., Meier, Emily Reihm, Manwani, Deepa

Get full text

Active Study: Impact of Voxelotor on Sleep Quality, Physical Activity, and Patient-Reported Outcomes by Shah, Nirmish, Brown, Clark, Andemariam, Biree, Idowu, Modupe, Glaros, Alexander, Glassberg, Jeffrey, Cronin, Robert M, Moehring, Barbara, Hoppe, Carolyn, Dixon, Sandy, Manwani, Deepa

Get full text

Making the Case for EGFR TKI Sequencing in EGFR Mutation-Positive NSCLC: A Giotag Study US Patient Analysis by Feinberg, Bruce, Halmos, Balazs, Gucalp, Rasim, Tang, Wenbo, Moehring, Barbara, Hochmair, Maximillian J

“…Aim: To assess time-to-treatment failure (TTF) in US patients with EGFR mutation-positive non-small-cell lung cancer (NSCLC) who received sequential…”
Get full text